In short. Five mechanisms are proposed for filler fatigue. Two are claims about appearance, two are reported but unsettled, and two are asserted without demonstration.
Key points
- A finding described in practice and consistent with a mechanism is worth taking seriously.
- It is not the same as a finding that has been measured.
- This review grades the two claims above as limited rather than promoting them to established because they sound plausible.
Five mechanisms are proposed for what filler fatigue is supposed to be. Placing them side by side, with what would be needed to demonstrate each, is more useful than arguing about the label. Two of the five are claims about appearance rather than tissue, and the two kinds are often mixed in one sentence.
Claim one: volume accumulates
This is not a tissue claim at all, and it is the one that is established. Volume added across several areas over several years accumulates unless something removes it, and a face carrying more than its structure supports reads heavier. Nothing here requires a change in tissue, and it fits the observations without needing anything else.
Claim two: volume is replaced by scar tissue
Graded limited. Fibrous change around repeatedly treated areas is described in practice, and it would explain a firmness that does not resolve. It has not been demonstrated as a general consequence of treatment, and it cannot be confirmed in a living face without sampling tissue that nobody samples for this reason. Plausible, reported, unquantified.
Claim three: material moves from where it was placed
Also graded limited. Displacement is reported, is sometimes seen on imaging, and is a credible explanation for fullness appearing where nothing was injected. What is not established is how often it occurs, how far material travels, or that it is the usual explanation for a face that looks different years later. The claim is reasonable; its size is unknown.
Reported is not demonstrated
A finding described in practice and consistent with a mechanism is worth taking seriously. It is not the same as a finding that has been measured. This review grades the two claims above as limited rather than promoting them to established because they sound plausible.
Claim four: the tissue is fatigued
Not supported. There is no established process by which filler exhausts skin or tissue, no measurement that demonstrates it, and no agreed definition of what fatigue would mean if it did. The word does the work of a mechanism without any of the content, which is why it is the claim most worth being sceptical about: it is the claim built into the name.
Claim five: a face becomes dependent on more filler
Not supported. Faces do not develop a requirement for volume. What happens is a sequence of decisions: added volume changes how a face reads, the change is gradual, and the next decision is made against a new baseline. That describes a pattern of choices rather than a dependence, and the difference is not only semantic, because a dependence sounds like something that must be treated.
Seek care if
- Severe pain out of proportion to an injection, or skin turning white, grey, mottled or dusky — a vascular emergency; seek care immediately.
- Any change in vision after a facial injection — emergency care immediately.
- A lump that is growing, tender or warm, or skin changes over an area that was treated some time ago.
Frequently asked questions
What is the evidence that filler damages tissue?
There is no established demonstration of it. Fibrous change around repeatedly treated areas is described and displacement of material is sometimes seen on imaging, and both are graded as limited here. The claim that filler fatigues skin or tissue is not supported by any measurement, and it is the claim the name itself carries.
Could filler still be present years after treatment?
Some can be, and how much and for how long is not predictable in an individual. What is not supported is any confident statement about quantity: examination gives an impression rather than a measurement, records are frequently incomplete, and imaging is not used in routine practice for this. Anyone quoting a figure is not quoting a measurement.
Why is it so hard to prove what happens in tissue?
Because the relevant tissue is in a living face. Confirming what is there would mean sampling it, which nobody does for this reason, and imaging does not separate placed material from scar change from the tissue around it. Confident claims are therefore easy to make and difficult to check, which is exactly the condition under which unsupported claims spread.
Risks & Limitations
- Every filler result is temporary, and maintenance treatment is usually part of a plan over years.
- Over-treatment is harder to correct than under-treatment, and removing volume depends on which substance class was used.
- Vascular occlusion is a time-critical emergency that can cause skin loss and, rarely, vision loss.
- Dissolving is a treatment with its own risks, not a reset: it acts on one substance class and cannot be confirmed to have removed everything.
When to Seek Care
- Severe pain out of proportion to an injection, or skin turning white, grey, mottled or dusky — a vascular emergency; seek care immediately.
- Any change in vision after a facial injection — seek emergency care immediately.
- A firm tender lump, or redness and swelling appearing weeks to months after treatment rather than settling.
- Skin breakdown, blistering or a wound at an injection site, or fever with spreading redness and warmth.
References & Further Reading
- American Society of Plastic Surgeons (ASPS) — procedure and safety guidance
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. It is an evidence review rather than a booking page, and it does not steer anyone towards treatment. Discuss your own case with a qualified clinician; to ask a question about the content of this review, see Contact & Consultation.